iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Shares Shorted: Short Interest Down 55.2% in September

by · The Markets Daily

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report) was the target of a significant decrease in short interest in the month of September. As of September 15th, there was short interest totaling 23,081 shares, a decrease of 55.2% from the August 31st total of 51,524 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average daily volume of 151,159 shares, the days-to-cover ratio is presently 0.2 days.

Hedge Funds Weigh In On iShares Genomics Immunology and Healthcare ETF

A hedge fund recently bought a new stake in iShares Genomics Immunology and Healthcare ETF stock. Anchor Investment Management LLC acquired a new stake in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 2,898 shares of the company’s stock, valued at approximately $98,000.

iShares Genomics Immunology and Healthcare ETF Stock Up 2.0%

iShares Genomics Immunology and Healthcare ETF stock traded up $0.84 during mid-day trading on Tuesday, hitting $42.63. The company’s stock had a trading volume of 518,601 shares, compared to its average volume of 61,327. The stock’s fifty day moving average price is $37.51 and its two-hundred day moving average price is $32.89. The stock has a market capitalization of $292.02 million, a P/E ratio of 14.76 and a beta of 0.95. iShares Genomics Immunology and Healthcare ETF has a twelve month low of $23.10 and a twelve month high of $42.72.

iShares Genomics Immunology and Healthcare ETF Company Profile

(Get Free Report)

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

See Also